These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28444776)

  • 21. Astemizole and an analogue promote fungicidal activity of fluconazole against Cryptococcus neoformans var. grubii and Cryptococcus gattii.
    Vu K; Gelli A
    Med Mycol; 2010 Mar; 48(2):255-62. PubMed ID: 19572230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Cryptococcal activity of a furanone derivative-antibiofilm and opsonophagocytic potential.
    Rathore SS; Raman T; Lalitha C; Ramar M; Munusamy A; Ramakrishnan J
    J Mycol Med; 2020 Jun; 30(2):100924. PubMed ID: 32037102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral infection caused by Cryptococcus gattii: a case report and antifungal susceptibility testing.
    Soares BM; Santos DA; Kohler LM; da Costa César G; de Carvalho IR; dos Anjos Martins M; Cisalpino PS
    Rev Iberoam Micol; 2008 Dec; 25(4):242-5. PubMed ID: 19071894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans.
    Li Y; Chang W; Zhang M; Li X; Jiao Y; Lou H
    FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25752309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
    Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
    Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii Isolates.
    Cong L; Liao Y; Yang S; Yang R
    PLoS One; 2016; 11(12):e0167903. PubMed ID: 27930704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans.
    Thompson GR; Wiederhold NP; Fothergill AW; Vallor AC; Wickes BL; Patterson TF
    Antimicrob Agents Chemother; 2009 Jan; 53(1):309-11. PubMed ID: 18955539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of verapamil alone and in combination with fluconazole or tunicamycin against Candida albicans biofilms.
    Yu Q; Ding X; Xu N; Cheng X; Qian K; Zhang B; Xing L; Li M
    Int J Antimicrob Agents; 2013 Feb; 41(2):179-82. PubMed ID: 23265915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryptococcus neoformans serotype A and Cryptococcus gattii serotype B isolates differ in their susceptibilities to fluconazole and voriconazole.
    Khan ZU; Randhawa HS; Chehadeh W; Chowdhary A; Kowshik T; Chandy R
    Int J Antimicrob Agents; 2009 Jun; 33(6):559-63. PubMed ID: 19195846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic effect of doxycycline and fluconazole against Candida albicans biofilms and the impact of calcium channel blockers.
    Gao Y; Zhang C; Lu C; Liu P; Li Y; Li H; Sun S
    FEMS Yeast Res; 2013 Aug; 13(5):453-62. PubMed ID: 23577622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous cryptococcosis due to Cryptococcus diffluens in a patient with sporotrichoid lesions case report, features of the case isolate and in vitro antifungal susceptibilities.
    Kantarcioğlu AS; Boekhout T; De Hoog GS; Theelen B; Yücel A; Ekmekci TR; Fries BC; Ikeda R; Koslu A; Altas K
    Med Mycol; 2007 Mar; 45(2):173-81. PubMed ID: 17365654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro interactions between fluconazole and minocycline against mixed cultures of Candida albicans and Staphylococcus aureus.
    Li H; Zhang C; Liu P; Liu W; Gao Y; Sun S
    J Microbiol Immunol Infect; 2015 Dec; 48(6):655-61. PubMed ID: 24856422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeated isolation of Cryptococcus laurentii from the oropharynx of an immunocompromized patient.
    Bauters TG; Swinne D; Boekhout T; Noens L; Nelis HJ
    Mycopathologia; 2002; 153(3):133-5. PubMed ID: 11998874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific antibody to Cryptococcus neoformans glucurunoxylomannan antagonizes antifungal drug action against cryptococcal biofilms in vitro.
    Martinez LR; Christaki E; Casadevall A
    J Infect Dis; 2006 Jul; 194(2):261-6. PubMed ID: 16779734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluconazole and amphotericin B susceptibility testing of Cryptococcus neoformans: results of minimal inhibitory concentrations against 265 isolates from HIV-positive patients before and after two or more months of antifungal therapy.
    Arechavala AI; Ochiuzzi ME; Borgnia MD; Santiso GM
    Rev Iberoam Micol; 2009 Sep; 26(3):194-7. PubMed ID: 19635445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effects of tea catechin epigallocatechin gallate and antimycotics against oral Candida species.
    Ning Y; Ling J; Wu CD
    Arch Oral Biol; 2015 Oct; 60(10):1565-70. PubMed ID: 26263544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
    Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
    J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coordination to gallium(III) strongly enhances the potency of 2-pyridineformamide thiosemicarbazones against Cryptococcus opportunistic fungi.
    Bastos Tde O; Soares BM; Cisalpino PS; Mendes IC; dos Santos RG; Beraldo H
    Microbiol Res; 2010 Sep; 165(7):573-7. PubMed ID: 20015626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temperature affects the susceptibility of Cryptococcus neoformans biofilms to antifungal agents.
    Pettit RK; Repp KK; Hazen KC
    Med Mycol; 2010 Mar; 48(2):421-6. PubMed ID: 19637092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.